Leerink Partners Announces $130 Price Target for Nektar Therapeutics
Leerink Partners announced a $130.00-per-share price target for Nektar Therapeutics.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.